Users assume all risks associated with experimental compound use
January 28, 2025 New Study, More Concern A recent study published in JAMA OtolaryngologyHead & Neck Surgery has added another layer of concern to the growing Noro Nordisk Ozempic lawsuits and the broader litigation over GLP-1 receptor agonists
Publication Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma
We used primary antibodies against astrocytes (anti-GFAP, Dako, 1:400 dilution), microglia (anti-Iba-1, Wako, 1:200 dilution), and ICAM-1 (Monoclonal Antibody for CD54, ICAM1, eBioKAT-1, eBioscience)
Days 2-4: The Adjustment Phase What to expect: This is when most side effects appear